Abstract
Cardiovascular disease (CVD) remains the leading cause of death among women worldwide, with significant disparities in prevalence, outcomes, and care. Despite these alarming statistics, research on women’s heart health remains underfunded and poorly prioritized, due in part to the historic exclusion of women from clinical trials and biomedical research. This editorial will highlight the scope of CVD in women, explore sex- and gender-specific risk factors such as gestational diabetes, early menopause, and psychosocial stress, and underscore barriers to quality care including implicit bias and structural inequities. It also calls for increased representation of women in clinical trials and medical fields. Policy and funding shifts are urgently needed to encourage sex-specific research and equitable healthcare delivery. This editorial concludes with a call to action for inclusive, interdisciplinary research approaches, that centers women and their unique biological realities. Advancing gender-responsive cardiovascular care will require not only scientific innovation but also institutional accountability and societal commitment to health equity.
| Original language | English |
|---|---|
| Number of pages | 5 |
| Journal | Women's Health |
| Volume | 21 |
| Early online date | 16 Dec 2025 |
| DOIs | |
| Publication status | Published - Dec 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2025. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Keywords
- sex- and gender-based medicine
- cardiovascular diseases in women
- health equity
- clinical trial representation